Baxter Intl: (NYSE: BAX)
$72.94
1.09 (1.52%)
Volume 7,436,530
May 17 04:00 PM ET
Zacks Rank: 3-Hold 
| #3 |
Overview Quote
Stock Activity
| Day Low - High | 71.95 - 73.40 |
| 52wk Low - High | 48.98 - 73.40 |
| Previous Close | 71.85 |
| Avg. Volume | 4,530,235 |
| Industry | MED PRODUCTS |
| Market Cap | 39.63 B |
| Div - Yield | 1.80 - 2.47 |
| Beta | 0.51 |
| PE (Forward) | 15.67 |
| Current Year Est. | 4.66 |
| Quarterly Earnings ESP |
0.00% |
Premium research
Zacks Rank
|
 3 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
175 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | 15.67 |
| PEG Ratio | 1.76 |
| Current Year Est. | 4.66 |
| Current Quarter Estimate | 1.13 |
| Most Accurate Estimate | 1.13 |
| Earnings ESP |
0.00% |
| Next Earnings Report Date | 07-18-2013 |
| EPS Last Year | 4.57 |
| Expected Earnings Growth | 8.91% |
Company Description
Baxter engages in the worldwide development, manufacture and distribution of a diversified line of products, systems and services used primarily in the health-care field. The company's products are used by hospitals, clinical and medical research laboratories, blood and dialysis centers, rehabilitation centers, nursing homes, doctors' offices and by patients, at home, under physician supervision.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | 1.13 | 1.18 | 4.66 | 5.15 |
| Number of Estimates | 12 | 11 | 15 | 13 |
| Low Estimate | 1.12 | 1.14 | 4.62 | 5.00 |
| High Estimate | 1.14 | 1.21 | 4.71 | NA |
| Year Ago EPS | 1.12 | 1.14 | 4.53 | 4.66 |
| EPS Growth | 0.89% | 3.11% | 2.77% | 10.54% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| BAXTER INTL | BAX | 72.94 | |
|
| CONCEPTUS INC | CPTS | 30.92 | |
|
| ATRICURE INC | ATRC | 9.07 | |
|
| CYTOSORBENTS CP | CTSO | 0.12 | |
|
| INVIVO THERAPT | NVIV | 2.89 | |
|
| TRANS1 INC | TSON | 1.70 | |
|
| ABAXIS INC | ABAX | 45.35 | |
|
| ADVAXIS INC | ADXS | 0.05 | |
|
| ALERE INC | ALR | 26.30 | |
|
| BIO-RAD LABS -A | BIO | 116.02 | |
|
Sector:Medical>> Industry:MED PRODUCTS
COMPARE TICKER vs. Its Peers
Zacks Commentary
Tiffany Hikes Dividend
May 17, 2013
Fresenius Teams with ApolloMed
May 15, 2013
Fresenius Earnings Lower Y/Y
May 01, 2013
Reiterate Baxter at Neutral
Apr 23, 2013
Company News for April 19, 2013
Apr 19, 2013
Baxter Earnings Beat on EPS, Miss on Rev
Apr 18, 2013
Becton Receives 510(k) Clearance
Apr 15, 2013
Fresenius Teams with HCACO
Apr 09, 2013
Financials
| EPS TTM | 4.57 |
| Sales | 14,190 |
| Net Income | 2,290 |
| Price/Earnings | 15.96 |
| Price/Book | 5.66 |
| Price/Cash Flow | 12.41 |
| Price/Sales | 2.78 |
News
Cramer`s Top Stock Picks: BSX BAX FB - TheStreet.com
May 18, 2013
Diagnosing Alzheimer`s First - TheMotleyFool
May 17, 2013
Shares of Baxter International Rise Above Previous 52-Week High - Financial News Netwfork Online - 52-Week High-Lows
May 17, 2013
Baxter International (BAX) Trading Near $69.82 Support Level - Freshbrewedmedia
May 16, 2013
7 Dividend Stocks Sending More Cash to Shareholders - GuruFocus
May 13, 2013
AUPHA Awards Dorothy Rice, Sc.D. with William B. Graham Prize for Health Services Research - Close-Up Media
May 13, 2013
BRIEF: Teva mulling acquisition in South Africa - report - Mcclatchy-Tribune Information Services -- Unrestricted
May 13, 2013
My 3 Favorite Stocks With A Dividend Growth From Last Week - GuruFocus
May 12, 2013
Broker Recommendations
| Current ABR | 1.75 |
| ABR (Last Week) | 1.75 |
| # of recs in ABR | 18 |
| Average Target Price | 74.38 |
| Industry Rank by ABR | 175 out of 265 |
| Rank in Industry | 6 out of 72 |
